research Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.
Rosario, SF, Argentina
Incomplete name
Aiea, HI, United States
Circoiscrizione VI, Italy
São Paulo, SP, Brazil
San Diego, CA, United States
Zaragoza, Aragon, Spain



